Leukosight Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Leukosight General Information

Description

Provider of anti-inflammatory therapeutics. The company offers therapeutics that can be used to treat auto-immune and inflammatory diseases.

Contact Information

Website
www.leukosight.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1107 Microbiology Building
  • 231 B Campus Drive
  • College Park, MD 20742
  • United States
+1 (301)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • 1107 Microbiology Building
  • 231 B Campus Drive
  • College Park, MD 20742
  • United States
+1 (301)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leukosight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Generating Revenue
4. Grant 03-May-2012 Completed Startup
3. Grant 01-Jan-2012 Completed Startup
2. Early Stage VC Completed Startup
1. Grant 01-May-2009 $150K Completed Startup
To view Leukosight’s complete valuation and funding history, request access »

Leukosight Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Leukosight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100143353-A1 Polypeptides comprising fc fragments of immunoglobulin g (lgg) and methods of using the same Inactive 04-Dec-2008
US-20120283417-A1 Polypeptides comprising fc fragments of immunoglobulin g (igg) and methods of using the same Inactive 04-Dec-2008
US-20140294817-A1 Polypeptides comprising fc fragments of immunoglobulin g (igg) and methods of using the same Inactive 04-Dec-2008 C07K16/244

Leukosight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Leukosight Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Maryland Biotechnology Center Government
National Institute for Allergy and Infectious Disease Government
TEDCO Venture Capital Minority
To view Leukosight’s complete investors history, request access »

Ready to get started?

Request a free trial

Leukosight FAQs

  • When was Leukosight founded?

    Leukosight was founded in 2006.

  • Where is Leukosight headquartered?

    Leukosight is headquartered in College Park, MD.

  • What is the size of Leukosight?

    Leukosight has 5 total employees.

  • What industry is Leukosight in?

    Leukosight’s primary industry is Drug Discovery.

  • Is Leukosight a private or public company?

    Leukosight is a Private company.

  • What is Leukosight’s current revenue?

    The current revenue for Leukosight is .

  • Who are Leukosight’s investors?

    Maryland Biotechnology Center, National Institute for Allergy and Infectious Disease, and TEDCO have invested in Leukosight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »